• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BNT162b2 新冠病毒疫苗接种及其对血压的影响。

BNT162b2 COVID-19 Vaccination and Its Effect on Blood Pressure.

机构信息

Department of Emergency Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.

Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malayia, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.

出版信息

Medicina (Kaunas). 2022 Dec 5;58(12):1789. doi: 10.3390/medicina58121789.

DOI:10.3390/medicina58121789
PMID:36556993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9786719/
Abstract

: The objective of this study is to examine the effect of the BNT162b2 vaccine on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure (PP) before and 15 min after two doses that were given 21 days apart. : This active surveillance study of vaccine safety was conducted on 15 and 16 March (for the first dose) and 5 and 6 April (for the second dose) 2021 in an academic hospital. For both doses, SBP, DBP, MAP, and PP levels were measured before and 15 min after both doses were given to healthcare workers over the age of 18. The results of the study were based on measurements of the mean blood pressure (BP), the mean changes in BP, and the BP trends. : In total, 287 individuals received the vaccine. After the first dose, 25% ( = 72) of individuals had a decrease in DBP of at least 10 mmHg (mean DBP decrease: 15 mmHg, 95% CI: 14-17 mmHg), and after the second dose it was 12.5% (mean DBP decrease: 13 mmHg, 95% CI: 12-15 mmHg). After the first dose, 28.6% ( = 82) had a PP that was wider than 40 mmHg. After the first dose, 5.2% and 4.9% of the individuals experienced an increase or decrease in SBP, respectively, of more than 20 mmHg. After the second dose, the SBP of 11% ( = 32) decreased by at least 20 mmHg. : Improved understanding of vaccine effects on BP may help address vaccine hesitancy in healthcare workers.

摘要

: 本研究旨在探讨相隔 21 天接种两剂 BNT162b2 疫苗对收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)和脉压(PP)的影响,观察在两剂疫苗接种前及接种后 15 分钟时的血压变化。 : 本疫苗安全性主动监测研究于 2021 年 3 月 15 日和 16 日(第一剂)以及 4 月 5 日和 6 日(第二剂)在一家学术医院进行。对两剂疫苗均测量了 18 岁以上医护人员接种前和接种后 15 分钟的 SBP、DBP、MAP 和 PP 水平。研究结果基于平均血压(BP)测量值、BP 变化平均值和 BP 趋势。 : 总计 287 人接种了疫苗。第一剂后,25%(=72 人)的 DBP 下降至少 10mmHg(平均 DBP 下降:15mmHg,95%CI:14-17mmHg),第二剂后这一比例为 12.5%(平均 DBP 下降:13mmHg,95%CI:12-15mmHg)。第一剂后,28.6%(=82 人)的 PP 大于 40mmHg。第一剂后,5.2%和 4.9%的个体 SBP 分别升高或降低超过 20mmHg。第二剂后,11%(=32 人)的 SBP 至少下降 20mmHg。 : 更好地了解疫苗对 BP 的影响可能有助于解决医护人员对接种疫苗的犹豫。

相似文献

1
BNT162b2 COVID-19 Vaccination and Its Effect on Blood Pressure.BNT162b2 新冠病毒疫苗接种及其对血压的影响。
Medicina (Kaunas). 2022 Dec 5;58(12):1789. doi: 10.3390/medicina58121789.
2
Central blood pressure and pulse wave velocity in young and middle-aged Japanese adults with isolated systolic hypertension.中青年单纯收缩期高血压患者的中心血压和脉搏波速度。
Hypertens Res. 2020 Mar;43(3):207-212. doi: 10.1038/s41440-019-0364-x. Epub 2019 Nov 29.
3
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
4
Trends of blood pressure control in the U.S. during the COVID-19 pandemic.美国在 COVID-19 大流行期间的血压控制趋势。
Am Heart J. 2022 May;247:15-23. doi: 10.1016/j.ahj.2021.11.017. Epub 2021 Dec 10.
5
Changes in ophthalmic artery Doppler during acute blood-pressure control in hypertensive pregnant women.高血压孕妇急性血压控制期间眼动脉多普勒的变化。
Ultrasound Obstet Gynecol. 2022 Feb;59(2):185-191. doi: 10.1002/uog.23755.
6
Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.生长激素替代治疗对成年人生长激素缺乏症患者24小时动态血压及其昼夜节律的影响。
Clin Endocrinol (Oxf). 2002 Apr;56(4):431-7. doi: 10.1046/j.1365-2265.2002.01491.x.
7
Association of blood pressure components with mortality and cardiovascular events in prehypertensive individuals: a nationwide population-based cohort study.血压成分与高血压前期个体死亡和心血管事件的关联:一项全国范围内基于人群的队列研究。
Ann Med. 2018 Aug;50(5):443-452. doi: 10.1080/07853890.2018.1492146. Epub 2018 Jul 21.
8
Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.75 岁及以上成年人接种 BNT162b2 新冠疫苗后的安全性监测。
J Korean Med Sci. 2021 Nov 22;36(45):e318. doi: 10.3346/jkms.2021.36.e318.
9
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.在高危患者中实现了目标收缩压(120-140mmHg)下的舒张压和脉压,并取得了心血管结局:ONTARGET 和 TRANSCEND 试验的结果。
Eur Heart J. 2018 Sep 1;39(33):3105-3114. doi: 10.1093/eurheartj/ehy287.
10
[A correlation of pulse pressure and prognosis of refractory septic shock patients].[脉压与难治性感染性休克患者预后的相关性]
Zhonghua Nei Ke Za Zhi. 2014 Feb;53(2):121-6.

本文引用的文献

1
COVID-19-Related Vaccine Hesitancy among Community Hospitals' Healthcare Workers in Singapore.新加坡社区医院医护人员中与新冠病毒疾病相关的疫苗犹豫情况
Vaccines (Basel). 2022 Mar 30;10(4):537. doi: 10.3390/vaccines10040537.
2
Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France.mRNA-新冠病毒托珠单抗疫苗接种后的血压测量:法国一家大学医院的回顾性分析
J Hum Hypertens. 2022 Jun;36(6):580-581. doi: 10.1038/s41371-021-00634-0. Epub 2022 Jan 6.
3
Short term blood pressure alterations in recently COVID-19 vaccinated patients.近期接种新冠疫苗患者的短期血压变化
Eur J Intern Med. 2022 Feb;96:115-116. doi: 10.1016/j.ejim.2021.11.017. Epub 2021 Nov 29.
4
COVID-19 Vaccine Hesitancy-A Scoping Review of Literature in High-Income Countries.新冠疫苗犹豫——高收入国家文献的范围综述
Vaccines (Basel). 2021 Aug 13;9(8):900. doi: 10.3390/vaccines9080900.
5
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine.辉瑞/生物科技公司的新冠病毒疫苗接种后血压升高。
Eur J Intern Med. 2021 Aug;90:111-113. doi: 10.1016/j.ejim.2021.06.013. Epub 2021 Jun 16.
6
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.在接受 mRNA-1273 疫苗接种者的血浆中检测到循环严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗抗原。
Clin Infect Dis. 2022 Mar 1;74(4):715-718. doi: 10.1093/cid/ciab465.
7
SARS-CoV-2 vaccines: Lights and shadows.SARS-CoV-2 疫苗:光明与阴影。
Eur J Intern Med. 2021 Jun;88:1-8. doi: 10.1016/j.ejim.2021.04.019. Epub 2021 Apr 30.
8
COVID-19: Insights into Potential Vaccines.新型冠状病毒肺炎:对潜在疫苗的见解
Microorganisms. 2021 Mar 15;9(3):605. doi: 10.3390/microorganisms9030605.
9
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination.基于mRNA的SARS-CoV-2疫苗接种后患者的III期高血压
Hypertension. 2021 Jun;77(6):e56-e57. doi: 10.1161/HYPERTENSIONAHA.121.17316. Epub 2021 Mar 25.
10
BNT162b2 mRNA COVID-19 Vaccine: First Approval.BNT162b2 mRNA COVID-19 疫苗:首次批准。
Drugs. 2021 Mar;81(4):495-501. doi: 10.1007/s40265-021-01480-7.